Previous studies show that mutations in the CASR gene can cause Mendelian disorders, wherein loss-of-function mutations lead to familial hypocalciuric hypercalcemia (FHH), while gain-of-function mutations can give rise to autosomal-dominant hypocalcemia or type 5 of Bartter syndrome [7]. The gene discussed is CASR; the disease is autosomal dominant hypocalcemia.